Text: State's Parmly on Sale of Human Organs in China
(Parmly calls practice "egregious human rights abuse")

Principal Deputy Assistant Secretary of State of the Bureau for Democracy, Human Rights and Labor Michael E. Parmly testified before members of Congress June 27 about what the State Department is doing to put an end to "the repugnant practice of coercive organ harvesting" and trafficking in organs that occurs in China.

Parmly told the House of Representatives Subcommittee on International Operations and Human Rights that even though Chinese regulations outlaw the buying and selling of human tissues and organs, enforcement of these regulations is "woefully inadequate."

"The anecdotal and circumstantial evidence regarding the practice of removing organs from executed prisoners for sale to foreigners and wealthy Chinese is substantial, credible, and growing," Parmly said in prepared testimony.

He characterized as "deeply troubling" reports of Americans receiving organ transplants in China.

"The Department of State is also aware of reports that it cannot independently confirm, of other, even more egregious practices, such as removing organs from still-living prisoners, and scheduling executions to accommodate the need for particular organs," he added.

"The lack of due process and consent [in China], coupled with credible evidence of harvesting organs from executed prisoners and from hospital cadavers, raises serious human rights concerns," Parmly said.

The State Department has repeatedly raised the issue of organ harvesting and trafficking with high-level Chinese officials since the 1990s, and in the past month had discussed the topic on separate occasions with several senior Chinese Embassy officials, including Assistant Foreign Minister Zhou Wenzhong, Parmly told the lawmakers.

State Department officials are pressing the Chinese government to enact and implement legislation or regulations that prohibit removing organs from executed prisoners, he added.

The United States is also encouraging changes in China's legal and medical systems to ensure the protection of individual rights and the guarantee of due process, Parmly said.

In the meantime, U.S. officials are monitoring and publicizing the situation, he said.

"We have also covered the issue of organ harvesting in our annual human rights report on China to put the spotlight of international attention on this issue," Parmly added.

"In the weeks and months ahead, we will step up our efforts to work with countries in the region, with allies, and other like-minded countries to put an end to organ trafficking. And, finally, we are committed to investigating and prosecuting to the fullest extent of our own law any criminal acts over which the United States has jurisdiction," Parmly concluded.

In the United States, Federal Bureau of Prisons regulations do not allow organ donation by federal prisoners, unless the donation is to an immediate family member. Other countries have similarly strict laws and regulations regarding organ donations by prisoners.

Following is the text of Parmly's testimony, as prepared for delivery:

(begin text)

Statement of
Michael E. Parmly
Principal Deputy Assistant Secretary of State
Bureau for Democracy, Human Rights and Labor
Department of State

At a hearing entitled
"Sale of Human Organs in China"

Before the
House International Relations
Subcommittee on International Operations and Human Rights

June 27, 2001

Chairwoman Ros-Lehtinen and Members of the Committee, thank you for the opportunity to appear at this important hearing to address the issue of the sale of human organs in China. The removal of organs from executed prisoners without proper permission from family members along with the trafficking in these organs is a serious, deeply disturbing subject that raises a number of profoundly important human rights issues. The State Department welcomes the opportunity to update the committee on our assessment of the problem and what the Department is doing to encourage China to put an end to this abhorrent practice. As you know, reports of Chinese authorities removing organs from executed prisoners in China, without the consent of the prisoners or their families, are not new. The Hong Kong and London press carried the numerous reports as early as the mid-1980s, when the introduction of the drug Cyclosoporine-A made transplants a newly viable option for patients.

Our concern about such practices is also not new. We repeatedly raised this issue with high-level Chinese officials throughout the 1990s, pressing for changes in Chinese policy and practice, and urging changes in China's legal and medical systems to ensure the protection of individual rights and the guarantee of due process. We have also covered the issue of organ harvesting in our annual human rights report on China to put the spotlight of international attention on this issue. We consider organ harvesting from executed prisoners, without permission from family members, to be an egregious human rights abuse that violates not only international human rights law, but also international medical ethical standards.

Unfortunately, despite our efforts, as well as those of human rights activists like Harry Wu, human rights organizations, and concerned medical professionals, the practice of harvesting organs from executed prisoners continues in China. The lack of transparency in the Chinese criminal justice system and the secrecy that surrounds prison executions and the removal of organs makes actual documentation of the practice impossible. However, the anecdotal and circumstantial evidence regarding the practice of removing organs from executed prisoners for sale to foreigners and wealthy Chinese is substantial, credible, and growing. It cannot be ignored. Credible sources include public statements by patients who have had transplants in China, doctors who have provided post-transplant care to these patients in the United States and elsewhere, and testimony by Chinese doctors and former officials who claim to have witnessed or taken part in such practices or to have seen incriminating evidence.

In the past, according to available evidence, the majority of patients receiving transplants in China came from other parts of Asia, including Malaysia, Singapore, Taiwan, and Thailand. A leading kidney specialist in Malaysia has estimated that over 1000 Malaysians alone have had kidney transplants in China. More recently, deeply troubling reports of Americans receiving transplants in China have been made public. American doctors, including Dr. Thomas Diflo, who will be testifying in a later panel, have reported seeing transplant patients from China in need of follow-up care. These patients have stated that they were informed by hospital personnel in China that the organs that they received came from executed prisoners.

The Department of State is also aware of reports that it cannot independently confirm, of other, even more egregious practices, such as removing organs from still-living prisoners, and scheduling executions to accommodate the need for particular organs. In addition, there are compelling first-hand reports that doctors, in violation of medical ethics codes, have performed medical procedures to prepare condemned prisoners for execution and organ removal. As former Assistant Secretary John Shattuck testified before this committee in 1998, our concern about the abhorrent practice of removing organs from executed prisoners without consent is compounded by our concerns about the lack of due process. According to Amnesty International there were 1,263 confirmed executions in 1999; according to another report 800 prisoners were executed in May 2001 alone as the government conducted another "strike hard" campaign against crime. A high court nominally reviews all death sentences, but as our Country Report on Human Rights Practices points out, and as a recent New York Times article graphically described, the time between arrest and execution is often days or even hours. Some prisoners are taken directly from the courtroom to the execution grounds. Appeals of sentences consistently result in confirmation of sentence.

The lack of meaningful consent further compounds our concerns about this practice. According to Article 3 of China's Provisional Regulations on the Use of Executed Prisoners' Corpses or Organs , a corpse may be used for medical purposes if: nobody claims the body or the family refuses to bury it; the prisoner voluntarily donates the body for use by medical facilities; or the inmate's family consents to its use after death. The first category opens the door to abuse because families are often not notified of impending executions or are too far away or unable financially to make the trip to claim a relative's body. Also, bodies are routinely cremated immediately after a sentence is carried out, making it impossible even for those families who are able to claim a family member's remains to determine whether or not the body has been used for medical purposes.

Many have expressed the view that condemned prisoners and their families cannot make free and fully-voluntary decisions on organ donations because of the very nature of incarceration. In the United States, Federal Bureau of Prisons regulations do not allow organ donation by federal prisoners, unless the donation is to an immediate family member. Other countries have similarly strict laws and regulations regarding organ donations by prisoners.

Recent reports indicate that the phenomenon of organ trafficking has expanded beyond trafficking in the organs of executed prisoners. Our posts have reported increased numbers of Chinese media reports of organ harvesting from hospital cadavers by corrupt medical and hospital personnel, and the sale of organs by poor people for cash. This trade in human organs takes place openly, including on the Internet. Chinese web bulletin boards have reports of organs for sale and discussion of corruption in the "organ business." We are monitoring this trade closely and are raising our concerns with the Chinese government.

The lack of due process and consent, coupled with credible evidence of harvesting organs from executed prisoners and from hospital cadavers, raises serious human rights concerns. We, like Congress, are committed to press the Chinese authorities to take strong action to address human rights abuses wherever they occur. Despite the lack of transparency in China's legal system, we are making every effort to determine the magnitude of the problem and how effectively Chinese authorities have implemented Article 3 of China's Provisional Regulations on the Use of Executed Prisoners' Corpses or Organs (1984) and other pertinent regulations governing the practice of organ donations, sale and transplants. We are also pressing the Chinese to enact and implement legislation or regulations that prohibit removing organs from executed prisoners. In the weeks and months ahead, we will step up our efforts to work with countries in the region, with allies, and other like-minded countries to put an end to organ trafficking. And, finally, we are committed to investigating and prosecuting to the fullest extent of our own law any criminal acts over which the United States has jurisdiction. While we will continue to press the Chinese on this issue, we recognize the enormous challenge we face. The complex social issues in China involving severe rural poverty, along with corruption among poorly paid prison and hospital administrators who harvest organs from prisoners and patients without their consent, play a large role in this issue.

During the course of the 1990s, in response to repeated inquiries and demarches by the State Department, our ambassadors to China and other Embassy and State Department officials, the Chinese have provided information on their official policy, including two documents on regulations promulgated on April 6, 1996, governing organ donation. The regulations provide that "the buying or selling of human tissues and organs is not allowed. The donation or exchange of human tissue and organs with organizations or individuals outside national borders is not allowed." However, the Chinese have not responded to our inquiries about the extent and scope of harvesting and trafficking in human organs and about Chinese authorities' efforts to implement their own regulations.

We most recently discussed the issue of organ harvesting in Washington with the Ministry of Foreign Affairs (MFA) International Organization Director and senior Chinese Embassy officials on June 26. I participated in the meeting and specifically mentioned that I would be testifying before this committee today and would have to say that the United States was appalled by the number of highly credible reports coming out of China about the removal of organs from executed prisoners and about trafficking in those organs. I noted that enforcement of Chinese regulations governing organ donations appeared to be woefully inadequate. Our interlocutors responded that such practices are illegal in China and that those who are found to engage in such practices are brought to justice. I responded by asking that Chinese authorities provide us with evidence of such prosecutions. We also raised the issue on June 14 in Beijing with the MFA Human Rights Division Director and here in Washington with the Chinese Embassy. We informed Chinese Embassy officials of the increased level of attention being focused on this issue in the United States and urged China to work intensively to ensure that its organ transplant policies are consistent with international standards. We also urged China to take steps to combat the actions of those who engage in such unconscionable acts, pointing out that they are a perversion of medical ethics and state power as well as an egregious human rights violation.

Assistant Foreign Minister Zhou Wenzhong was in Washington last week and we communicated to him the strong bipartisan support that the issue of human rights has in the United States. In the months ahead, we will continue to make clear our strong opposition to the repugnant practice of coercive organ harvesting and will press the Government of China to ensure its organ transplant policies and practices are in compliance with international human rights norms as well as international medical practices. We will urge them to enforce all regulations governing organ transplants, to prosecute those who violate existing regulations, and to pass and implement new legislation. We also will share the testimonies delivered here today with our Embassy in China and instruct our Embassy to raise the allegations made in them with the appropriate officials in China. They will be asking Chinese authorities for evidence that those who engage in the practices discussed here today are brought to justice. In the United States we will investigate and prosecute all violators over whom the United States has jurisdiction to the fullest extent of the law.

Thank you.

(end text)

(Distributed by the Office of International Information Programs, U.S. Department of State. Web site: http://usinfo.state.gov)


Return to The United States and China.

Return to IIP Home Page.